Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Multicenter"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 64663
Tytuł:
Continual learning framework for a multicenter study with an application to electrocardiogram.
Autorzy:
Kim J; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea.
Lim MH; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.; Graduate School of Health Science and Technology, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea.
Kim K; Transdisciplinary Department of Medicine and Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.; Department of Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Yoon HJ; Interdisciplinary Program in Bioengineering, Seoul National University, Seoul, Republic of Korea. .; Medical Bigdata Research Center, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2024 Mar 06; Vol. 24 (1), pp. 67. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Journal Article
MeSH Terms:
Electrocardiography*
Multicenter Studies as Topic*
Humans ; Knowledge ; Privacy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.
Autorzy:
Wiedemann J; Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.
Hos D; Department of Ophthalmology, University Hospital Cologne, Cologne, Germany. .
Limburg E; Clinical Trials Centre of Cologne (CTCC), University of Cologne, Cologne, Germany.
Zettelmeyer U; Clinical Trials Centre of Cologne (CTCC), University of Cologne, Cologne, Germany.
Schiller P; Institute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine, University of Cologne, Cologne, Germany.
Franklin J; Institute of Medical Statistics and Computational Biology (IMSB), Faculty of Medicine, University of Cologne, Cologne, Germany.
Bachmann B; Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.
Böhringer D; Department of Ophthalmology, University of Freiburg, Freiburg, Germany.
Dietrich-Ntoukas T; Department of Ophthalmology, Charité - Universitaetsmedizin Berlin, corporate member of Freie Universitaet Berlin, Humboldt Universitaet zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Fuchsluger TA; Department of Ophthalmology, University of Rostock, Rostock, Germany.
Geerling G; Department of Ophthalmology, University of Düsseldorf, Düsseldorf, Germany.
Lang SJ; Department of Ophthalmology, University of Freiburg, Freiburg, Germany.
Mayer WJ; Department of Ophthalmology, LMU, University of Munich, Munich, Germany.
Priglinger S; Department of Ophthalmology, LMU, University of Munich, Munich, Germany.
Reinhard T; Department of Ophthalmology, University of Freiburg, Freiburg, Germany.
Seitz B; Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.
Cursiefen C; Department of Ophthalmology, University Hospital Cologne, Cologne, Germany.; CECAD Cluster of Excellence, University of Cologne, Cologne, Germany.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 06; Vol. 25 (1), pp. 169. Date of Electronic Publication: 2024 Mar 06.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Graft Survival*
Corneal Transplantation*/adverse effects
Humans ; Prospective Studies ; Quality of Life ; Ultraviolet Rays/adverse effects ; Cornea/surgery ; Blindness ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
LapEmerge trial: study protocol for a laparoscopic approach for emergency colon resection-a multicenter, open label, randomized controlled trial.
Autorzy:
Grönroos-Korhonen MT; Gastroenterological Surgery, Päijät-Häme Central Hospital, Keskussairaalankatu 7, 15850, Lahti, Finland. .; Helsinki University, Helsinki, Finland. .
Kössi JAO; Gastroenterological Surgery, Päijät-Häme Central Hospital, Keskussairaalankatu 7, 15850, Lahti, Finland.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 17; Vol. 25 (1), pp. 268. Date of Electronic Publication: 2024 Apr 17.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Colorectal Neoplasms*/surgery
Laparoscopy*/methods
Adult ; Humans ; Colectomy/methods ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The (cost-)effectiveness of early intervention (MBT-early) versus standard protocolized treatment (CBT) for emerging borderline personality disorder in adolescents (the EARLY study): a study protocol for a randomized controlled trial.
Autorzy:
Remeeus MGA; Behavioural Science Institute, Radboud University, Thomas Van Aquinostraat 4, Nijmegen, 6525GD, The Netherlands. .; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands. .
Clarke SL; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological disorders and Somatic diseases (CoRPS), Tilburg University, Warandelaan 2, Tilburg, 5037AB, The Netherlands.
Feenstra DJ; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical Psychology and Psychotherapy, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.
Van Eeren H; Department of Medical Psychology and Psychotherapy, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015GD, The Netherlands.
Smits ML; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.
Debruyne S; Mentaal Beter, Steijnlaan 12, Hilversum, 1217JS, The Netherlands.
Kouijzer MEJ; GGz Breburg, Poolseweg 190, Breda, 4818CG, The Netherlands.
Luyten P; Faculty of Psychology and Educational Sciences, University of Leuven, Dekenstraat 2, Leuven, 3000, Belgium.; Research Department of Clinical, Educational, and Health Psychology, University College London, Gower Street, London, WC1E 6BT, UK.
Scholte RHJ; Behavioural Science Institute, Radboud University, Thomas Van Aquinostraat 4, Nijmegen, 6525GD, The Netherlands.
Hutsebaut J; Viersprong Institute for Studies on Personality Disorders, Peter Vineloolaan 50, Bergen Op Zoom, 4611AN, The Netherlands.; Department of Medical and Clinical Psychology, Center of Research on Psychological disorders and Somatic diseases (CoRPS), Tilburg University, Warandelaan 2, Tilburg, 5037AB, The Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 15; Vol. 25 (1), pp. 261. Date of Electronic Publication: 2024 Apr 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Quality of Life*/psychology
Borderline Personality Disorder*/diagnosis
Borderline Personality Disorder*/therapy
Humans ; Adolescent ; Personality ; Anxiety ; Early Intervention, Educational ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Australasian Malignant PLeural Effusion (AMPLE)-4 trial: study protocol for a multi-centre randomised trial of topical antibiotics prophylaxis for infections of indwelling pleural catheters.
Autorzy:
Lau EPM; Pleural Medicine Unit, Institute for Respiratory Health, Perth, Australia.; School of Medical and Health Sciences, Edith Cowan University, Perth, Australia.
Ing M; Pleural Medicine Unit, Institute for Respiratory Health, Perth, Australia.; Medical School, Faculty of Health & Medical Sciences, University of Western Australia, Perth, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Vekaria S; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.; Department of Pharmacy, Sir Charles Gairdner Hospital, Perth, Australia.
Tan AL; Pleural Medicine Unit, Institute for Respiratory Health, Perth, Australia.
Charlesworth C; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia.
Fysh E; Medical School, Faculty of Health & Medical Sciences, University of Western Australia, Perth, Australia.; Department of Respiratory Medicine, St John of God Hospital Midland, Perth, Australia.; Curtin University Medical School, Perth, Australia.
Shrestha R; Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, Australia.
Yap ELC; Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand.
Smith NA; Department of Respiratory Medicine, Wellington Regional Hospital, Wellington, New Zealand.
Kwan BCH; Department of Respiratory and Sleep Medicine, The Sutherland Hospital, Sydney, Australia.; University of New South Wales, Sydney, Australia.
Saghaie T; Department of Respiratory Medicine, Concord Repatriation General Hospital, Concord, NSW, Australia.; Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia.
Roy B; Department of Respiratory and Sleep Medicine, Westmead Hospital, Sydney, Australia.
Goddard J; Department of Respiratory Medicine, Sunshine Coast University Hospital, Birtinya, QLD, Australia.; Griffith University, Brisbane, QLD, Australia.
Muruganandan S; Department of Respiratory Medicine, Northern Health, Epping, VIC, Australia.
Badiei A; Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.; Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, SA, Australia.
Nguyen P; Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, Australia.; Adelaide Medical School, Faculty of Health and Medical Science, University of Adelaide, Adelaide, SA, Australia.
Hamid MFA; Respiratory Unit, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
George V; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW, Australia.; Hunter Medical Research Institute, Newcastle, Australia.
Fitzgerald D; Department of Respiratory Medicine, Tallaght University Hospital, Dublin, Ireland.
Maskell N; Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Feller-Kopman D; Department of Medicine, Section of Pulmonary and Critical Care Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Murray K; School of Population and Global Health, University of Western Australia, Perth, Australia.
Chakera A; Medical School, Faculty of Health & Medical Sciences, University of Western Australia, Perth, Australia.; Renal Unit, Sir Charles Gairdner Hospital, Perth, Australia.
Lee YCG; Pleural Medicine Unit, Institute for Respiratory Health, Perth, Australia. .; Medical School, Faculty of Health & Medical Sciences, University of Western Australia, Perth, Australia. .; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 10; Vol. 25 (1), pp. 249. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Pleural Effusion, Malignant*/diagnosis
Pleural Effusion, Malignant*/complications
Catheter-Related Infections*/diagnosis
Catheter-Related Infections*/prevention & control
Humans ; Quality of Life ; Mupirocin/adverse effects ; Pleurodesis/methods ; Talc/therapeutic use ; Catheters, Indwelling/adverse effects ; Anti-Bacterial Agents/adverse effects ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The effects of telerehabilitation in adults with complex biventricular congenital heart conditions: protocol for a multi-centre, randomised controlled trial-CH-FIT.
Autorzy:
Wood G; School of Allied Health, Curtin University, Perth, WA, Australia. .; School of Science and Technology, Faculty of Science, Agriculture, Business and Law, University of New England, Armidale, NSW, Australia. .
Scheer A; School of Allied Health, Curtin University, Perth, WA, Australia.
Saundankar J; Perth Children's Hospital, Cardiology, Nedlands, Australia.; Sir Charles Gairdner Hospital, Cardiology, Nedlands, Australia.
Tran D; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Sydney Medical School, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Cordina R; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Sydney Medical School, Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
Maiorana A; School of Allied Health, Curtin University, Perth, WA, Australia.; Allied Health Department, Fiona Stanley Hospital, Perth, WA, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 05; Vol. 25 (1), pp. 239. Date of Electronic Publication: 2024 Apr 05.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Telerehabilitation*/methods
Adult ; Adolescent ; Humans ; Quality of Life ; Australia ; Exercise ; Exercise Therapy/methods ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparing psychological versus pharmacological treatment in emotional disorders: A network analysis.
Autorzy:
Jurado-González F; Department of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
García-Torres F; Department of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Contreras A; University Catholique San Antonio of Murcia, Murcia, Spain.
Muñoz-Navarro R; Department of Psychology and Sociology, Faculty of Social and Human Sciences, University of Zaragoza, Teruel, Spain.
González-Blanch C; Mental Health Centre, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Cantabria, Spain.
Adrián Medrano L; Faculty of Psychology, Siglo 21 University, De los Latinos, Cordoba, Argentina.
Ruiz-Rodríguez P; Castilla La Nueva Primary Care Centre, Health Service of Madrid, Fuenlabrada, Madrid, Spain.
Moreno EM; Department of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Pérez-Dueñas C; Department of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Cano-Vindel A; Faculty of Psychology, Complutense University of Madrid, Madrid, Spain.
Moriana JA; Department of Psychology, University of Cordoba/Maimonides Institute for Biomedical Research of Cordoba (IMIBIC)/Reina Sofia University Hospital, Cordoba, Spain.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 03; Vol. 19 (4), pp. e0301675. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Cognitive Behavioral Therapy*/methods
Humans ; Anxiety/therapy ; Anxiety Disorders/therapy ; Depression/therapy ; Mood Disorders ; Treatment Outcome ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
5-EPIFAT trial protocol: a multi-center, randomized, placebo-controlled trial of the efficacy of pharmacotherapy for fatigue using methylphenidate, bupropion, ginseng, and amantadine in advanced cancer patients on active treatment.
Autorzy:
Miladinia M; Nursing Care Research Center in Chronic Diseases, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. .
Jahangiri M; Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
White SJ; School of Nursing, Clayton State University, Morrow, GA, USA.
Karimpourian H; Department of Medical Oncology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Inno A; Medical Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella (VR), Italy.
Chan SW; Tung Wah College, Kowloon, Hong Kong.
Ganji R; Department of Clinical Pharmacy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Maniati M; School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Zarea K; Nursing Care Research Center in Chronic Diseases, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; School of Nursing and Midwifery, Deakin University, Burwood, VIC, Australia.
Ghalamkari M; Department of Internal Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Farahat A; Department of Hematology and Oncology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Fagerström C; Department of Health and Caring Sciences, Faculty of Health and Life Sciences, Linnaeus University, Kalmar/Växjö, Kalmar, Sweden.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 03; Vol. 25 (1), pp. 230. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Methylphenidate*/therapeutic use
Neoplasms*/therapy
Panax*
Adult ; Humans ; Amantadine/therapeutic use ; Bupropion/therapeutic use ; Fatigue/diagnosis ; Fatigue/drug therapy ; Fatigue/etiology ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.
Autorzy:
Khan I; Barts and the London Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. .
Taylor SJC; Barts and the London Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK. .
Robinson C; Barts and the London Pragmatic Clinical Trials Unit, Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Moschopoulou E; Barts and the London Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
McCrone P; Institute for Lifecourse Development, University of Greenwich, London, UK.
Bourke L; Dept. Allied Health Professionals, Sheffield Hallam University, Sheffield, UK.
Thaha M; Blizard Institute, Queen Mary University of London, London, UK.
Bhui K; Nuffield Department of Primary Care Health Sciences, Wadham College, University of Oxford, Oxford, UK.
Rosario D; The Academic Urology Unit, University of Sheffield, Sheffield, UK.
Ridge D; School of Social Sciences, University of Westminster, New Cavendish St, London, UK.
Donovan S; Barts and the London Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Korszun A; The Barts and the London Unit for Psychological Medicine, Centre for Psychiatry and Mental Health, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Little P; Primary Care Research Centre, Faculty of Medicine, University of Southampton, Southampton, UK.
Morgan A; Independent Cancer Patient's Voice (ICPV), 17 Woodbridge Street, London, UK.
Quentin O; Barts and the London Pragmatic Clinical Trials Unit, Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Roylance R; University College London Hospitals NHS Foundation Trust, London, UK.
White P; The Academic Urology Unit, University of Sheffield, Sheffield, UK.
Chalder T; Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London, DeCrespigny Park, London, UK.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Apr 02; Vol. 25 (1), pp. 228. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Pragmatic Clinical Trial; Clinical Trial Protocol; Journal Article
MeSH Terms:
Acceptance and Commitment Therapy*
Neoplasms*/therapy
Humans ; Quality of Life ; Aftercare ; Survivors ; Cost-Benefit Analysis ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal associations of screen time, physical activity, and sleep duration with body mass index in U.S. youth.
Autorzy:
Zink J; Division of Cancer Control and Population Sciences, Behavioral Research Program, Health Behaviors Research Branch, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA. .
Booker R; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Chicago, IL, 60611, USA.
Wolff-Hughes DL; Division of Cancer Control and Population Sciences, Epidemiology and Genomics Research Program, Risk Factors Assessment Branch, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.
Allen NB; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Chicago, IL, 60611, USA.
Carnethon MR; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Chicago, IL, 60611, USA.
Alexandria SJ; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N Lake Shore Drive, Chicago, IL, 60611, USA.
Berrigan D; Division of Cancer Control and Population Sciences, Behavioral Research Program, Health Behaviors Research Branch, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.
Pokaż więcej
Źródło:
The international journal of behavioral nutrition and physical activity [Int J Behav Nutr Phys Act] 2024 Apr 02; Vol. 21 (1), pp. 35. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Pediatric Obesity*/etiology
Child ; Female ; Humans ; Male ; Body Mass Index ; Exercise ; Screen Time ; Sedentary Behavior ; Sleep ; Sleep Duration ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol.
Autorzy:
Deng L; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Shayan G; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Jiang W; Department of Radiation Oncology, National Cancer Center/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bi N; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wang L; Department of Radiation Oncology, National Cancer Center/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Apr; Vol. 15 (11), pp. 938-943. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Small Cell Lung Carcinoma*/drug therapy
Small Cell Lung Carcinoma*/radiotherapy
Lung Neoplasms*/drug therapy
Humans ; Cisplatin ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/therapeutic use ; Progression-Free Survival ; Radiation Dosage ; Etoposide ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase III as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
Autorzy:
Lee KH; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea.
Yang IJ; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea.
Ha GW; Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju, Korea.
Lee J; Department of Surgery, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.
Park YY; Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
Lee SH; Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea.
Lee JM; Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Bae JH; Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Park EJ; Division of Colorectal Surgery, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Kim H; Department of Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim KY; Department of General Surgery, Wonkwang University Hospital & School of Medicine, Iksan, Korea.
An S; Department of Surgery, Yonsei University, Wonju College of Medicine, Wonju, Korea.
Kim IY; Department of Surgery, Yonsei University, Wonju College of Medicine, Wonju, Korea.
Kim JY; Department of Colorectal Surgery, Chungnam National University Hospital & College of Medicine, Daejeon, Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 29; Vol. 24 (1), pp. 397. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Colonic Neoplasms*/pathology
Adult ; Aged ; Humans ; Middle Aged ; Young Adult ; Chemotherapy, Adjuvant ; Clinical Trials, Phase II as Topic ; Disease-Free Survival ; Multicenter Studies as Topic ; Progression-Free Survival ; Randomized Controlled Trials as Topic ; Fluorouracil/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Study protocol for a prospective, randomized, multicenter trial to investigate the influence of peripheral nerve stimulation on patients with chronic sacroiliac joint syndrome (SILENCING).
Autorzy:
Sargut TA; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Tkatschenko D; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Früh A; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Tüttenberg J; Department of Neurosurgery, Clinical Center Idar-Oberstein, 55743, Idar-Oberstein, Germany.
Heckert A; Department of Neurosurgery, University of Oldenburg, Oldenburg, Germany.
Fleck S; Department of Neurosurgery, University Medicine Greifswald, Sauerbruchstrasse, Greifswald, Germany.
Kuckuck A; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Bayerl SH; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 28; Vol. 25 (1), pp. 223. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Low Back Pain*/diagnosis
Low Back Pain*/therapy
Chronic Pain*/diagnosis
Chronic Pain*/therapy
Spinal Cord Stimulation*/methods
Humans ; Sacroiliac Joint ; Quality of Life ; Prospective Studies ; Peripheral Nerves ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.
Autorzy:
Kuri A; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. .; Neurology and Neurosurgery Interest Group (NANSIG), London, UK. .
Henshall DE; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Deanery of Clinical Sciences, College of Medicine & Veterinary Medicine, The University of Edinburgh, Edinburgh, EH16 4SB, UK.
Chaudhry D; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Royal Stoke University Hospital, University Hospitals of North Midlands, Stoke-on-Trent, ST4 6QG, UK.
Ooi SZY; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
Zhang Q; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Mathews J; Department of Neurology, Royal London Hospital, London, UK.
Thomson A; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Rog D; Department of Neurology, Manchester Centre for Clinical Neurosciences, Salford, Manchester, M6 8HD, UK.
Hobart J; Peninsula Medical School, Faculty of Health, University of Plymouth, Plymouth, PL6 8BT, Great Britain.
Dobson R; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Pokaż więcej
Corporate Authors:
Neurology and Neurosurgery Interest Group (NANSIG)
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 28; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/epidemiology
Multiple Sclerosis*/drug therapy
Young Adult ; Humans ; Retrospective Studies ; Ireland/epidemiology ; United Kingdom/epidemiology ; Observational Studies as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
Autorzy:
McIlroy G; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK. .
Lax S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Gaskell C; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Jackson A; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Rhodes M; National Cancer Research Institute, London, UK.
Seale T; Division of Cancer Sciences, University of Manchester, Manchester, UK.
Fox S; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Hopkins L; Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
Okosun J; Barts Cancer Institute, Queen Mary University of London, London, UK.
Barrington SF; King's College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK.
Ringshausen I; UCL Cancer Institute, University College London, London, UK.
Ramsay AG; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Calaminici M; Department of Cellular Pathology Barts Health and Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
Linton K; Division of Cancer Sciences, University of Manchester, Manchester, UK.; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
Bishton M; Translational Medical Sciences, University of Nottingham, Nottingham, UK.; Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2024 Mar 25; Vol. 24 (1), pp. 370. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Lymphoma, Follicular*/drug therapy
Humans ; Positron Emission Tomography Computed Tomography ; Arm/pathology ; Bayes Theorem ; Quality of Life ; Treatment Outcome ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The ARIA trial protocol: a randomised controlled trial to assess the clinical, technical, and cost-effectiveness of a cloud-based, ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repair.
Autorzy:
Budge J; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.; St George's Vascular Institute, St George's University, London, UK.
Carrell T; Cydar Medical Limited, Cambridge, UK.
Yaqub M; King's Clinical Trials Unit, King's College London, London, UK.
Wafa H; Department of Population Health Sciences, King's College London, London, UK.
Waltham M; Cydar Medical Limited, Cambridge, UK.
Pilecka I; King's Clinical Trials Unit, King's College London, London, UK.
Kelly J; King's Clinical Trials Unit, King's College London, London, UK.
Murphy C; King's Clinical Trials Unit, King's College London, London, UK.
Palmer S; Centre for Health Economics, University of York, York, UK.
Wang Y; Department of Population Health Sciences, King's College London, London, UK.
Clough RE; School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 25; Vol. 25 (1), pp. 214. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Aortic Aneurysm, Abdominal*/diagnostic imaging
Aortic Aneurysm, Abdominal*/surgery
Endovascular Procedures*/methods
Blood Vessel Prosthesis Implantation*/adverse effects
Humans ; Cost-Benefit Analysis ; Cloud Computing ; Treatment Outcome ; Retrospective Studies ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).
Autorzy:
Streichart L; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Felldin M; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Ekberg J; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Mjörnstedt L; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Lindnér P; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Lennerling A; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden.
Bröcker V; Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Mölne J; Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Holgersson J; Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg and Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Daenen K; Department of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Wennberg L; Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden.
Lorant T; Section of Transplantation Surgery, Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
Baid-Agrawal S; Transplant Institute, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, 413 45, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 22; Vol. 25 (1), pp. 213. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Antibodies, Monoclonal, Humanized*/therapeutic use
Kidney Transplantation*/adverse effects
Humans ; Graft Rejection ; Kidney ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and histopathological characteristics of primary focal segmental glomerulosclerosis in Turkish adults.
Autorzy:
Kurultak I; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Trakya University, 22030, Edirne, Turkey. .
Gungor O; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Sutcu Imam University, Kahramanmaras, Turkey.
Ozturk S; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Istanbul University, Istanbul, Turkey.
Dirim AB; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Istanbul University, Istanbul, Turkey.
Eren N; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Kocaeli University, Kocaeli, Turkey.
Yenigün E; Department of Internal Medicine, Division of Nephrology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Dal EA; Department of Internal Medicine, Division of Nephrology, Health Science University, Istanbul Hamidiye Sisli Etfal Training and Research Hospital, Istanbul, Turkey.
Dincer MT; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Bora F; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Akdeniz University, Antalya, Turkey.
Akgur S; Department of Internal Medicine, Division of Nephrology, Kutahya Health Science University, Evliya Celebi Yuksek Ihtisas Training and Research Hospital, Kutahya, Turkey.
Sumnu A; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Medipol University, Istanbul, Turkey.
Dursun B; Faculty of Medicine, Department of InternalMedicine, Division of Nephrology, Pamukkale University, Denizli, Turkey.
Sipahi S; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Sakarya University, Sakarya, Turkey.
Cetinkaya H; Department of Internal Medicine, Division of Nephrology, Sultan Abdulhamid Training and Research Hospital, Istanbul, Turkey.
Sahin I; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Inonu University, Malatya, Turkey.
Sahin G; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Eskisehir Osmangazi University, Eskişehir, Turkey.
Yilmaz M; Department of Internal Medicine, Division of Nephrology, Health Science University, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
Vatansever B; Department of Internal Medicine, Division of Nephrology, Izmir Bozyaka Training and Research Hospital, Izmir, Turkey.
Aydın E; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Dicle University, Diyarbakir, Turkey.
Ulu MS; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Afyon Kocatepe University, Afyon, Turkey.
Gundogdu A; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Erciyes University, Kayseri, Turkey.
Ustundag S; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Trakya University, 22030, Edirne, Turkey.
Sayarlioglu H; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Samsun 19 Mayis University, Samsun, Turkey.
Kumru G; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Ankara University, Ankara, Turkey.
Elcioglu OC; Department of Internal Medicine, Division of Nephrology, Bezmialem Vakif University School of Medicine, Istanbul, Turkey.
Aydın Z; Department of Internal Medicine, Division of Nephrology, Darıca Farabi Training and Research Hospital, Kocaeli, Turkey.
Selcuk NY; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Selcuk University, Konya, Turkey.
Onal Guclu C; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Hacettepe University, Ankara, Turkey.
Oruc M; Department of Internal Medicine, Division of Nephrology, Kartal Lutfi Kirdar City Hospital, Istanbul, Turkey.
Kucuk M; Department of Internal Medicine, Division of Nephrology, Okmeydanı Training and Research Hospital, Istanbul, Turkey.
Aktas N; Department of Internal Medicine, Division of Nephrology, Health Science University, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey.
Derici U; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Gazi University, Ankara, Turkey.
Suleymanlar G; Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Akdeniz University, Antalya, Turkey.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 21; Vol. 14 (1), pp. 6748. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:
Journal Article
MeSH Terms:
Glomerulonephritis*
Glomerulosclerosis, Focal Segmental*/epidemiology
Glomerulosclerosis, Focal Segmental*/pathology
Adult ; Female ; Humans ; Male ; Biopsy ; Immunoglobulin M ; Proteinuria ; Retrospective Studies ; Serum Albumin ; Multicenter Studies as Topic ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation.
Autorzy:
Matlock DN; University of Arkansas for Medical Sciences, 4301 W. Markham St., Slot 512-5B, Little Rock, AR, 72205, USA. .; University of Arkansas for Medical Sciences, Little Rock, AR, USA. .
Ratcliffe SJ; University of Virginia, Charlottesville, VA, USA.
Courtney SE; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Kirpalani H; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; McMaster University, Hamilton, ON, Canada.
Firestone K; Akron Children's Hospital, Akron, OH, USA.
Stein H; Ebeid Children's Hospital, Toledo, OH, USA.
Dysart K; Nemours Children's Health Wilmington, Philadelphia, PA, USA.
Warren K; The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Goldstein MR; Loma Linda University School of Medicine, Loma Linda, CA, USA.
Lund KC; University of Utah, Salt Lake City, UT, USA.
Natarajan A; National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Demissie E; National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Foglia EE; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 20; Vol. 25 (1), pp. 201. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Interactive Ventilatory Support*/adverse effects
Interactive Ventilatory Support*/methods
Noninvasive Ventilation*/adverse effects
Noninvasive Ventilation*/methods
Infant ; Infant, Newborn ; Humans ; Intermittent Positive-Pressure Ventilation/adverse effects ; Infant, Extremely Premature ; Airway Extubation/adverse effects ; Prospective Studies ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase III as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bronchiolitis recovery and the use of High Efficiency Particulate Air (HEPA) Filters (The BREATHE Study): study protocol for a multi-center, parallel, double-blind, randomized controlled clinical trial.
Autorzy:
Cowan K; Department of Pediatrics, Larner College of Medicine at the University of Vermont, 111 Colchester Ave, Smith 5, Burlington, VT, 05403, USA. .
Semmens EO; School of Public and Community Health Sciences, University of Montana, 177 Skaggs, Missoula, MT, 59812-2016, USA.
Lee JY; University of Arkansas for Medical Sciences, 4301 West Markham, #781, Little Rock, AR, 72205, USA.
Walker ES; School of Public and Community Health Sciences, University of Montana, 177 Skaggs, Missoula, MT, 59812-2016, USA.
Smith PG; School of Public and Community Health Sciences, University of Montana, 177 Skaggs, Missoula, MT, 59812-2016, USA.
Fu L; National Institutes of Health Environmental Influences On Child, Health Outcomes (ECHO) Program, 11601, Landsdown Street, Rockville, MD, 20852, USA.
Singleton R; Alaska Native Tribal Health Consortium, AIP-CDC, 4055 Tudor Centre Drive, Anchorage, AK, 99508, USA.
Cox SM; School of Public and Community Health Sciences, University of Montana, 177 Skaggs, Missoula, MT, 59812-2016, USA.
Faiella J; School of Public and Community Health Sciences, University of Montana, 177 Skaggs, Missoula, MT, 59812-2016, USA.
Chassereau L; University of Vermont, Given C421, 89 Beaumont Ave, Burlington, VT, 05405, USA.
Lawrence L; IDeA States Pediatric Network Data Coordination and Operations Center, 13 Children's Way, Slot 512-35, Little Rock, AR, 72202, USA.
Ying J; Department of Family Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop F496, Academic Office One L15-3407, 12631 E 17th Avenue, Aurora, CO, 80045, USA.
Baldner J; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, AR, 72205, USA.
Garza M; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, 4301 W Markham Street, Little Rock, AR, 72205, USA.
Annett R; University of New Mexico Health Sciences Center, Albuquerque, NM, 87106, USA.
Chervinskiy SK; Cook Children's Department of Immunology, 1500 Cooper St, Fort Worth, TX, 76104, USA.
Snowden J; IDeA States Pediatric Network Data Coordination and Operations Center, 13 Children's Way, Slot 512-35, Little Rock, AR, 72202, USA.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 20; Vol. 25 (1), pp. 197. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Air Filters*
Air Pollution, Indoor*/adverse effects
Air Pollution, Indoor*/prevention & control
Asthma*
Bronchiolitis*/diagnosis
Bronchiolitis*/prevention & control
Child ; Infant ; Humans ; Quality of Life ; Particulate Matter/adverse effects ; Dust ; Carbon ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 64663

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies